Sections |
| Title | Starting Page | Number of Pages |
|---|
| CHAPTER ONE Executive Summary | 9 | 3 |
| WHAT'S NEW IN CHINA | 12 | 2 |
| MOLECULAR DIAGNOSTICS IN CHINA | 13 | 3 |
| COMPANY PROFILES | 16 | 1 |
| A Note on Names and Spelling | 17 | 1 |
| Abbreviations Used in This Report: | 18 | 1 |
| CHAPTER TWO Country Summary | 19 | 1 |
| WHAT'S NEW IN CHINA | 19 | 3 |
| The Healthcare System in China | 21 | 3 |
| Privatization | 23 | 1 |
| Private and Reference Laboratories | 23 | 2 |
| Private Medical Practice | 24 | 1 |
| Medical Insurance | 24 | 3 |
| A Brief Guide to the Bureaucracy | 26 | 1 |
| PRODUCT REGISTRATION | 27 | 2 |
| The "Clean" Campaign | 28 | 4 |
| Reimbursement | 31 | 2 |
| Tenders | 32 | 1 |
| Reagent Rental | 33 | 1 |
| Quality Control | 33 | 2 |
| Vacuum Tube Conversion | 34 | 1 |
| Consolidated Work Stations and Sample Automation | 34 | 2 |
| Second-hand Instruments | 35 | 1 |
| CHAPTER THREE Market Analysis | 36 | 1 |
| COMMENTARY | 36 | 2 |
| MARKET LEADERS | 42 | 2 |
| Pricing and Reimbursement | 43 | 2 |
| Quality Issues | 45 | 2 |
| Other Molecular Products | 46 | 1 |
| Domestic Companies | 47 | 3 |
| International Companies | 49 | 2 |
| CHAPTER FOUR Company Profiles | 52 | 1 |
| ABBOTT LABORATORIES | 52 | 1 |
| Company Information | 52 | 1 |
| Company Description | 52 | 28 |
| APPLIED BIOSYSTEMS | 54 | 1 |
| Company Information | 54 | 5 |
| AMPLLY | 55 | 1 |
| BIOER TECHNOLOGY | 56 | 1 |
| BIO-HEMA | 57 | 1 |
| BIOMERIEUX (FRANCE) | 58 | 1 |
| BAYER HEALTHCARE (US) | 60 | 1 |
| Company Information | 60 | 1 |
| DA AN GENE | 62 | 1 |
| Company Information | 62 | 13 |
| ELIKAN BIOLOGICAL TECHNOLOGY | 63 | 1 |
| FOSUN DIAGNOSTICS | 64 | 1 |
| GENE COMPANY | 65 | 1 |
| HAOYUAN BIOTECHNOLOGY | 66 | 1 |
| HEALTHDIGIT | 67 | 1 |
| INTEC PRODUCTS | 68 | 1 |
| KEHUA BIOTECH | 69 | 1 |
| LENGGUANG TECHNOLOGY | 70 | 1 |
| PROMEGA (US) | 71 | 1 |
| PG (PIGI) | 72 | 1 |
| QIAGEN | 73 | 1 |
| ROCHE | 74 | 1 |
| SCIARRAY BIOTECH | 76 | 1 |
| Company Information | 76 | 2 |
| SCIENCE INTERNATIONAL/SCIENCE LABORATORIES | 77 | 1 |
| SINO-AMERICAN BIOTECHNOLOGY COMPANY (SABC) | 79 | 1 |
| Company Information | 79 | 1 |
Tables |
| Title | Starting Page | Number of Pages |
|---|
| Exhibit 2 Molecular Diagnostics in China, 2006 | 14 | 1 |
| Exhibit 3 Hospitals in China by Level (Level I, II, III, A, B, C and Unrated) | 22 | 1 |
| Exhibit 4 Hospitals in China by Number of Beds | 22 | 1 |
| Exhibit 6 Reagent Sales in China (Infectious Disease, Other) | 38 | 1 |
| Exhibit 7 Instrument Sales in China | 39 | 1 |
| Exhibit 8 Molecular Diagnostics in China (RMB and $ US) | 39 | 1 |
| Exhibit 12 Average Price Lists for PCR Tests | 43 | 1 |
| Exhibit 13 Key Analytes (Analyte, Market Share) | 44 | 1 |
| Exhibit 14 Reimbursement Range for Kinetic Molecular Testing | 44 | 1 |
| Exhibit 15 Molecular Testing Distribution Companies | 47 | 1 |
Graphs |
| Title | Starting Page | Number of Pages |
|---|
| Exhibit 1 Chinese IVD Market, 1996- 2006 | 9 | 1 |
| Exhibit 9 Reagent Market in China by Category (Kinetic/QPCR, Traditional, Other) | 40 | 1 |
| Exhibit 10 Instruments in China by Category (End Point, Kinetic) | 41 | 1 |
| Exhibit 11 Market Leaders | 42 | 1 |
